Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Sayegh

Showing results (31-40 of 202) with videos related to

Pageof 21
Sort By:
Transplantation|May 15, 1994
Mechanisms of T cell recognition of alloantigen. The role of peptidesM H Sayegh, B Watschinger, C B Carpenter
Seminars in Nephrology|April 4, 2000
Chronic allograft dysfunction: mechanisms and new approaches to therapyK L Womer, J P Vella, M H Sayegh
Pediatric Transplantation|September 16, 1999
Transplantation tolerance: the concept and its applicabilityV M Dong, K L Womer, M H Sayegh
Transplantation Proceedings|October 1, 1992
In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4W W Hancock, M H Sayegh, C B Carpenter
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1991
Membranous nephropathy in a patient with renal cell carcinomaM E Cudkowicz, M H Sayegh, H G Rennke
Pediatric Transplantation|March 20, 1999
Developments in the clinical science of transplantation during the 20th centuryJ P Vella, M H Sayegh, L A Turka
Journal of the American Society of Nephrology : JASN|March 1, 1994
Late renal allograft failure secondary to thrombotic microangiopathy-human immunodeficiency virus nephropathyG J Frem, H G Rennke, M H Sayegh
Lancet (London, England)|April 13, 1999
Immunosuppressive strategies in transplantationM D Denton, C C Magee, M H Sayegh
Human Immunology|October 1, 1989
Anti-CD4 monoclonal antibody effects cellular hyporesponsiveness and prolongs renal allograft survival in the ratM H Sayegh, J P Kut, E L Milford
Transplantation|April 27, 1996
T cell recognition of xeno-MHC peptides during concordant xenograft rejectionB Murphy, H Auchincloss, C B Carpenter, et al.
Pageof 21

Showing results (31-40 of 202) with videos related to

Sort By:
Pageof 21
Transplantation|May 15, 1994
Mechanisms of T cell recognition of alloantigen. The role of peptidesM H Sayegh, B Watschinger, C B Carpenter
Seminars in Nephrology|April 4, 2000
Chronic allograft dysfunction: mechanisms and new approaches to therapyK L Womer, J P Vella, M H Sayegh
Pediatric Transplantation|September 16, 1999
Transplantation tolerance: the concept and its applicabilityV M Dong, K L Womer, M H Sayegh
Transplantation Proceedings|October 1, 1992
In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4W W Hancock, M H Sayegh, C B Carpenter
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1991
Membranous nephropathy in a patient with renal cell carcinomaM E Cudkowicz, M H Sayegh, H G Rennke
Pediatric Transplantation|March 20, 1999
Developments in the clinical science of transplantation during the 20th centuryJ P Vella, M H Sayegh, L A Turka
Journal of the American Society of Nephrology : JASN|March 1, 1994
Late renal allograft failure secondary to thrombotic microangiopathy-human immunodeficiency virus nephropathyG J Frem, H G Rennke, M H Sayegh
Lancet (London, England)|April 13, 1999
Immunosuppressive strategies in transplantationM D Denton, C C Magee, M H Sayegh
Human Immunology|October 1, 1989
Anti-CD4 monoclonal antibody effects cellular hyporesponsiveness and prolongs renal allograft survival in the ratM H Sayegh, J P Kut, E L Milford
Transplantation|April 27, 1996
T cell recognition of xeno-MHC peptides during concordant xenograft rejectionB Murphy, H Auchincloss, C B Carpenter, et al.
Pageof 21